P. Rysavka, M. Kohutková-Lánová, R. Netušil, E. Pospíšilová, M. Hanácˇková, J. Cˇmielová, K. Št’astný, I. Márová, M. Haranta, A. Bomba
{"title":"个性化益生菌对肠道微生物群的定向调节","authors":"P. Rysavka, M. Kohutková-Lánová, R. Netušil, E. Pospíšilová, M. Hanácˇková, J. Cˇmielová, K. Št’astný, I. Márová, M. Haranta, A. Bomba","doi":"10.37290/ijpp2641-7197.17:33-41","DOIUrl":null,"url":null,"abstract":"The current market of probiotic supplements is significantly growing although the quality and effectiveness of the commonly sold products are variable. Parameters such as the composition of each individual microbiota, strain specificity, production procedures, or storage can influence the potential positive outcome of probiotic supplements on consumers. The aim of this study was to determine changes of selected markers within the microbiota after 3 months treatment by the personalized probiotic supplement. Stool samples of 48 volunteers were analyzed by 16s ribsosomal RNA sequencing. The composition (selection of species, number of species used, and number of colony-forming units) of the probiotic mixture was designed based on the gut microbiota analysis and it was prepared for each patient separately. After 3 months of probiotic supplementation, a control sample was analyzed. Data confirmed a statistically significant increase in abundance of genera Lactobacillus and Bifidobacterium and phylum Actinobacteria. The overall number of species was also increased thus increasing the overall diversity of the microbiota, which is considered a marker of healthy gut microbiota.","PeriodicalId":53704,"journal":{"name":"International Journal of Probiotics and Prebiotics","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Targeted Modulation of Gut Microbiota by Personalized Probiotics\",\"authors\":\"P. Rysavka, M. Kohutková-Lánová, R. Netušil, E. Pospíšilová, M. Hanácˇková, J. Cˇmielová, K. Št’astný, I. Márová, M. Haranta, A. Bomba\",\"doi\":\"10.37290/ijpp2641-7197.17:33-41\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The current market of probiotic supplements is significantly growing although the quality and effectiveness of the commonly sold products are variable. Parameters such as the composition of each individual microbiota, strain specificity, production procedures, or storage can influence the potential positive outcome of probiotic supplements on consumers. The aim of this study was to determine changes of selected markers within the microbiota after 3 months treatment by the personalized probiotic supplement. Stool samples of 48 volunteers were analyzed by 16s ribsosomal RNA sequencing. The composition (selection of species, number of species used, and number of colony-forming units) of the probiotic mixture was designed based on the gut microbiota analysis and it was prepared for each patient separately. After 3 months of probiotic supplementation, a control sample was analyzed. Data confirmed a statistically significant increase in abundance of genera Lactobacillus and Bifidobacterium and phylum Actinobacteria. The overall number of species was also increased thus increasing the overall diversity of the microbiota, which is considered a marker of healthy gut microbiota.\",\"PeriodicalId\":53704,\"journal\":{\"name\":\"International Journal of Probiotics and Prebiotics\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Probiotics and Prebiotics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37290/ijpp2641-7197.17:33-41\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Probiotics and Prebiotics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37290/ijpp2641-7197.17:33-41","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Targeted Modulation of Gut Microbiota by Personalized Probiotics
The current market of probiotic supplements is significantly growing although the quality and effectiveness of the commonly sold products are variable. Parameters such as the composition of each individual microbiota, strain specificity, production procedures, or storage can influence the potential positive outcome of probiotic supplements on consumers. The aim of this study was to determine changes of selected markers within the microbiota after 3 months treatment by the personalized probiotic supplement. Stool samples of 48 volunteers were analyzed by 16s ribsosomal RNA sequencing. The composition (selection of species, number of species used, and number of colony-forming units) of the probiotic mixture was designed based on the gut microbiota analysis and it was prepared for each patient separately. After 3 months of probiotic supplementation, a control sample was analyzed. Data confirmed a statistically significant increase in abundance of genera Lactobacillus and Bifidobacterium and phylum Actinobacteria. The overall number of species was also increased thus increasing the overall diversity of the microbiota, which is considered a marker of healthy gut microbiota.
期刊介绍:
The International journal of Probiotics & Prebiotics publishes on online only in an open access format. This is a broad based international, interdisciplinary peer reviewed scientific journal for critical evaluation of research on prebiotics, probiotics and synbiotics. The major goal of this journal is to provide unbiased scientific data to students, researchers, healthcare providers, and the decision makers in the nutraceutical industry to help make informed choices about prebiotics, probiotics and synbiotics. To this end, the journal will publish original research articles and two types of review articles. First, we will publish a review of preclinical research data coming largely from animal, cell culture and other experimental models. Such data will provide basis for future product development and/or human research initiatives. Second, we will publish a critical evaluation of current human experimental data to help deliver products with medically proven use.